Corder E.H.

Saunders A.M.

Strittmatter W.J.

Schmechel D.E.

Gaskell P.C.

Small G.W.

et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 261 : 921-923 View in Article PubMed

Crossref

Google Scholar

Mahley R.W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240 : 622-630 View in Article PubMed

Crossref

Google Scholar

Mahley R.W.

Rall Jr., S.C. Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 1 : 507-537 View in Article PubMed

Crossref

Google Scholar

Weisgraber K.H.

Rall Jr., S.C.

Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem. 256 : 9077-9083 View in Article PubMed

Google Scholar

Xu Q.

Bernardo A.

Walker D.

Kanegawa T.

Mahley R.W.

Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 26 : 4985-4994 View in Article Scopus (170)

PubMed

Crossref

Google Scholar

Casey C.S.

Atagi Y.

Yamazaki Y.

Shinohara M.

Tachibana M.

Fu Y.

et al. Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway. J Biol Chem. 290 : 14208-14217 View in Article Scopus (8)

PubMed

Crossref

Google Scholar

Wahrle S.E.

Jiang H.

Parsadanian M.

Legleiter J.

Han X.

Fryer J.D.

et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem. 279 : 40987-40993 View in Article Scopus (251)

PubMed

Crossref

Google Scholar

Weisgraber K.H. Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112. J Lipid Res. 31 : 1503-1511 View in Article PubMed

Google Scholar

Lane-Donovan C.

Wong W.M.

Durakoglugil M.S.

Wasser C.R.

Jiang S.

Xian X.

et al. Genetic restoration of plasma apoE improves cognition and partially restores synaptic defects in apoE-deficient mice. J Neurosci. 36 : 10141-10150 View in Article PubMed

Crossref

Google Scholar

Linton M.F.

Gish R.

Hubl S.T.

Butler E.

Esquivel C.

Bry W.I.

et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest. 88 : 270-281 View in Article PubMed

Crossref

Google Scholar

Baker-Nigh A.T.

Mawuenyega K.G.

Bollinger J.G.

Ovod V.

Kasten T.

Franklin E.E.

et al. Human central nervous system (CNS) apoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared to plasma. J Biol Chem. 291 : 27204-27218 View in Article Scopus (3)

PubMed

Crossref

Google Scholar

Ulrich J.D.

Burchett J.M.

Restivo J.L.

Schuler D.R.

Verghese P.B.

Mahan T.E.

et al. In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. Mol Neurodegener. 8 : 13 View in Article Scopus (42)

PubMed

Crossref

Google Scholar

Morrow J.A.

Hatters D.M.

Lu B.

Hochtl P.

Oberg K.A.

Rupp B.

et al. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J Biol Chem. 277 : 50380-50385 View in Article Scopus (136)

PubMed

Crossref

Google Scholar

Ruiz J.

Kouiavskaia D.

Migliorini M.

Robinson S.

Saenko E.L.

Gorlatova N.

et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 46 : 1721-1731 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Ji Z.S.

Brecht W.J.

Miranda R.D.

Hussain M.M.

Innerarity T.L.

Mahley R.W. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 268 : 10160-10167 View in Article PubMed

Google Scholar

Saito H.

Dhanasekaran P.

Nguyen D.

Baldwin F.

Weisgraber K.H.

Wehrli S.

et al. Characterization of the heparin binding sites in human apolipoprotein E. J Biol Chem. 278 : 14782-14787 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Schneider W.J.

Kovanen P.T.

Brown M.S.

Goldstein J.L.

Utermann G.

Weber W.

et al. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest. 68 : 1075-1085 View in Article PubMed

Crossref

Google Scholar

Kowal R.C.

Herz J.

Weisgraber K.H.

Mahley R.W.

Brown M.S.

Goldstein J.L. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem. 265 : 10771-10779 View in Article PubMed

Google Scholar

Gonneaud J.

Arenaza-Urquijo E.M.

Fouquet M.

Perrotin A.

Fradin S.

de La Sayette V.

et al. Relative effect of APOE epsilon4 on neuroimaging biomarker changes across the lifespan. Neurology. 87 : 1696-1703 View in Article Scopus (1)

PubMed

Crossref

Google Scholar

Kantarci K.

Lowe V.

Przybelski S.A.

Weigand S.D.

Senjem M.L.

Ivnik R.J.

et al. APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology. 78 : 232-240 View in Article Scopus (88)

PubMed

Crossref

Google Scholar

Murphy K.R.

Landau S.M.

Choudhury K.R.

Hostage C.A.

Shpanskaya K.S.

Sair H.I.

et al. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth. Neuroimage. 78 : 474-480 View in Article Scopus (20)

PubMed

Crossref

Google Scholar

Berlau D.J.

Corrada M.M.

Head E.

Kawas C.H. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology. 72 : 829-834 View in Article Scopus (90)

PubMed

Crossref

Google Scholar

Tai L.M.

Youmans K.L.

Jungbauer L.

Yu C.

Ladu M.J. Introducing human APOE into Abeta transgenic mouse models. Int J Alzheimers Dis. 2011 : 810981 View in Article PubMed

Google Scholar

Hudry E.

Dashkoff J.

Roe A.D.

Takeda S.

Koffie R.M.

Hashimoto T.

et al. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med. 5 : 212ra161 View in Article Scopus (47)

PubMed

Crossref

Google Scholar

Zhao W.

Dumanis S.B.

Tamboli I.Y.

Rodriguez G.A.

Jo Ladu M.

Moussa C.E.

et al. Human APOE genotype affects intraneuronal Abeta1-42 accumulation in a lentiviral gene transfer model. Hum Mol Genet. 23 : 1365-1375 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Youmans K.L.

Tai L.M.

Nwabuisi-Heath E.

Jungbauer L.

Kanekiyo T.

Gan M.

et al. APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 287 : 41774-41786 View in Article Scopus (76)

PubMed

Crossref

Google Scholar

Garai K.

Verghese P.B.

Baban B.

Holtzman D.M.

Frieden C. The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry. 53 : 6323-6331 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Wood S.J.

Chan W.

Wetzel R. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry. 35 : 12623-12628 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Prince J.A.

Zetterberg H.

Andreasen N.

Marcusson J.

Blennow K. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology. 62 : 2116-2118 View in Article PubMed

Crossref

Google Scholar

Castellano J.M.

Kim J.

Stewart F.R.

Jiang H.

DeMattos R.B.

Patterson B.W.

et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med. 3 : 89ra57 View in Article Scopus (409)

PubMed

Crossref

Google Scholar

Lautner R.

Palmqvist S.

Mattsson N.

Andreasson U.

Wallin A.

Palsson E.

et al. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiatry. 71 : 1183-1191 View in Article PubMed

Crossref

Google Scholar

Cruchaga C.

Kauwe J.S.

Nowotny P.

Bales K.

Pickering E.H.

Mayo K.

et al. Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer’s disease. Hum Mol Genet. 21 : 4558-4571 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Waldron E.

Heilig C.

Schweitzer A.

Nadella N.

Jaeger S.

Martin A.M.

et al. LRP1 modulates APP trafficking along early compartments of the secretory pathway. Neurobiol Dis. 31 : 188-197 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Pietrzik C.U.

Yoon I.S.

Jaeger S.

Busse T.

Weggen S.

Koo E.H. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci. 24 : 4259-4265 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Zerbinatti C.V.

Wozniak D.F.

Cirrito J.

Cam J.A.

Osaka H.

Bales K.R.

et al. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A. 101 : 1075-1080 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Pietrzik C.U.

Busse T.

Merriam D.E.

Weggen S.

Koo E.H. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J. 21 : 5691-5700 View in Article Scopus (156)

PubMed

Crossref

Google Scholar

Ye S.

Huang Y.

Mullendorff K.

Dong L.

Giedt G.

Meng E.C.

et al. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A. 102 : 18700-18705 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Hopkins P.C.

Sainz-Fuertes R.

Lovestone S. The impact of a novel apolipoprotein E and amyloid-beta protein precursor-interacting protein on the production of amyloid-beta. J Alzheimers Dis. 26 : 239-253 View in Article PubMed

Google Scholar

Fuentealba R.A.

Liu Q.

Zhang J.

Kanekiyo T.

Hu X.

Lee J.M.

et al. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One. 5 : e11884 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Xu G.

Green C.C.

Fromholt S.E.

Borchelt D.R. Reduction of low-density lipoprotein receptor-related protein (LRP1) in hippocampal neurons does not proportionately reduce, or otherwise alter, amyloid deposition in APPswe/PS1dE9 transgenic mice. Alzheimers Res Ther. 4 : 12 View in Article Scopus (10)

PubMed

Crossref

Google Scholar

Kanekiyo T.

Liu C.C.

Shinohara M.

Li J.

Bu G. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer’s amyloid-beta. J Neurosci. 32 : 16458-16465 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Basak J.M.

Verghese P.B.

Yoon H.

Kim J.

Holtzman D.M. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem. 287 : 13959-13971 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

de Oliveira J.

Moreira E.L.

dos Santos D.B.

Piermartiri T.C.

Dutra R.C.

Pinton S.

et al. Increased susceptibility to amyloid-beta-induced neurotoxicity in mice lacking the low-density lipoprotein receptor. J Alzheimers Dis. 41 : 43-60 View in Article PubMed

Google Scholar

Katsouri L.

Georgopoulos S. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer’s disease mouse model. PLoS One. 6 : e21880 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Castellano J.M.

Deane R.

Gottesdiener A.J.

Verghese P.B.

Stewart F.R.

West T.

et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis. Proc Natl Acad Sci U S A. 109 : 15502-15507 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Reynolds M.R.

Singh I.

Azad T.D.

Holmes B.B.

Verghese P.B.

Dietrich H.H.

et al. Heparan sulfate proteoglycans mediate Abeta-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells. Mol Neurodegener. 11 : 9 View in Article Scopus (1)

PubMed

Crossref

Google Scholar

Kanekiyo T.

Zhang J.

Liu Q.

Liu C.C.

Zhang L.

Bu G. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci. 31 : 1644-1651 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Liu C.C.

Zhao N.

Yamaguchi Y.

Cirrito J.R.

Kanekiyo T.

Holtzman D.M.

et al. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer’s disease. Sci Transl Med. 8 : 332ra344 View in Article Scopus (17)

Crossref

Google Scholar

Fu Y.

Zhao J.

Atagi Y.

Nielsen H.M.

Liu C.C.

Zheng H.

et al. Apolipoprotein E lipoprotein particles inhibit amyloid-beta uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener. 11 : 37 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

LaDu M.J.

Falduto M.T.

Manelli A.M.

Reardon C.A.

Getz G.S.

Frail D.E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 269 : 23403-23406 View in Article PubMed

Google Scholar

Reger M.A.

Watson G.S.

Green P.S.

Baker L.D.

Cholerton B.

Fishel M.A.

et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis. 13 : 323-331 View in Article PubMed

Crossref

Google Scholar

Claxton A.

Baker L.D.

Hanson A.

Trittschuh E.H.

Cholerton B.

Morgan A.

et al. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer’s disease dementia. J Alzheimers Dis. 44 : 897-906 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Deane R.

Sagare A.

Hamm K.

Parisi M.

Lane S.

Finn M.B.

et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 118 : 4002-4013 View in Article Scopus (350)

PubMed

Crossref

Google Scholar

Verghese P.B.

Castellano J.M.

Garai K.

Wang Y.

Jiang H.

Shah A.

et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci U S A. 110 : E1807-E1816 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Farris W.

Mansourian S.

Chang Y.

Lindsley L.

Eckman E.A.

Frosch M.P.

et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 100 : 4162-4167 View in Article Scopus (887)

PubMed

Crossref

Google Scholar

Miller B.C.

Eckman E.A.

Sambamurti K.

Dobbs N.

Chow K.M.

Eckman C.B.

et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A. 100 : 6221-6226 View in Article Scopus (220)

PubMed

Crossref

Google Scholar

Du J.

Chang J.

Guo S.

Zhang Q.

Wang Z. ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons. Neurosci Lett. 464 : 140-145 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Mulder S.D.

Veerhuis R.

Blankenstein M.A.

Nielsen H.M. The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes. Exp Neurol. 233 : 373-379 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Liu D.S.

Pan X.D.

Zhang J.

Shen H.

Collins N.C.

Cole A.M.

et al. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Mol Neurodegener. 10 : 7 View in Article Scopus (23)

PubMed

Crossref

Google Scholar

Nakajima C.

Kulik A.

Frotscher M.

Herz J.

Schafer M.

Bock H.H.

et al. Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes. J Biol Chem. 288 : 21909-21923 View in Article Scopus (23)

PubMed

Crossref

Google Scholar

Sen A.

Alkon D.L.

Nelson T.J. Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon. J Biol Chem. 287 : 15947-15958 View in Article Scopus (32)

PubMed

Crossref

Google Scholar

Hayashi H.

Campenot R.B.

Vance D.E.

Vance J.E. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J Neurosci. 27 : 1933-1941 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Chen Y.

Durakoglugil M.S.

Xian X.

Herz J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A. 107 : 12011-12016 View in Article Scopus (124)

PubMed

Crossref

Google Scholar

Ge Y.

Dong Z.

Bagot R.C.

Howland J.G.

Phillips A.G.

Wong T.P.

et al. Hippocampal long-term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci U S A. 107 : 16697-16702 View in Article Scopus (122)

PubMed

Crossref

Google Scholar

Claxton A.

Baker L.D.

Wilkinson C.W.

Trittschuh E.H.

Chapman D.

Watson G.S.

et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease. J Alzheimers Dis. 35 : 789-797 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Salloway S.

Sperling R.

Fox N.C.

Blennow K.

Klunk W.

Raskind M.

et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med. 370 : 322-333 View in Article Scopus (589)

PubMed

Crossref

Google Scholar

Wahrle S.E.

Jiang H.

Parsadanian M.

Kim J.

Li A.

Knoten A.

et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 118 : 671-682 View in Article PubMed

Google Scholar

Riddell D.R.

Zhou H.

Comery T.A.

Kouranova E.

Lo C.F.

Warwick H.K.

et al. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer’s disease. Mol Cell Neurosci. 34 : 621-628 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Veeraraghavalu K.

Zhang C.

Miller S.

Hefendehl J.K.

Rajapaksha T.W.

Ulrich J.

et al. Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models”. Science. 340 ( ) View in Article Scopus (64)

PubMed

Crossref

Google Scholar

Tesseur I.

Lo A.C.

Roberfroid A.

Dietvorst S.

Van Broeck B.

Borgers M.

et al. Comment on “ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models”. Science. 340 ( ) View in Article Scopus (53)

PubMed

Crossref

Google Scholar

Tachibana M.

Shinohara M.

Yamazaki Y.

Liu C.C.

Rogers J.

Bu G.

et al. Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1. Exp Neurol. 277 : 1-9 View in Article PubMed

Crossref

Google Scholar

Tai L.M.

Koster K.P.

Luo J.

Lee S.H.

Wang Y.T.

Collins N.C.

et al. Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. J Biol Chem. 289 : 30538-30555 View in Article Scopus (33)

PubMed

Crossref

Google Scholar

Zhang X.

Hu J.

Zhong L.

Wang N.

Yang L.

Liu C.C.

et al. Quercetin stabilizes apolipoprotein E and reduces brain Abeta levels in amyloid model mice. Neuropharmacology. 108 : 179-192 View in Article Scopus (3)

PubMed

Crossref

Google Scholar

Zensi A.

Begley D.

Pontikis C.

Legros C.

Mihoreanu L.

Wagner S.

et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release. 137 : 78-86 View in Article Scopus (229)

PubMed

Crossref

Google Scholar

Hu J.

Liu C.C.

Chen X.F.

Zhang Y.W.

Xu H.

Bu G. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener. 10 : 6 View in Article Scopus (23)

PubMed

Crossref

Google Scholar

Bien-Ly N.

Gillespie A.K.

Walker D.

Yoon S.Y.

Huang Y. Reducing human apolipoprotein E levels attenuates age-dependent Abeta accumulation in mutant human amyloid precursor protein transgenic mice. J Neurosci. 32 : 4803-4811 View in Article Scopus (72)

PubMed

Crossref

Google Scholar

Kim J.

Eltorai A.E.

Jiang H.

Liao F.

Verghese P.B.

Stewart F.R.

et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis. J Exp Med. 209 : 2149-2156 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Liao F.

Hori Y.

Hudry E.

Bauer A.Q.

Jiang H.

Mahan T.E.

et al. Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis. J Neurosci. 34 : 7281-7292 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Mak A.C.

Pullinger C.R.

Tang L.F.

Wong J.S.

Deo R.C.

Schwarz J.M.

et al. Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function. JAMA Neurol. 71 : 1228-1236 View in Article Scopus (24)

PubMed

Crossref

Google Scholar

Chen H.K.

Liu Z.

Meyer-Franke A.

Brodbeck J.

Miranda R.D.

McGuire J.G.

et al. Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem. 287 : 5253-5266 View in Article Scopus (54)

PubMed

Crossref

Google Scholar

Medway C.W.

Abdul-Hay S.

Mims T.

Ma L.

Bisceglio G.

Zou F.

et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease. Mol Neurodegener. 9 : 11 View in Article PubMed

Crossref

Google Scholar

Frieden C.

Garai K. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease. Proc Natl Acad Sci U S A. 109 : 8913-8918 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Bales K.R.

Liu F.

Wu S.

Lin S.

Koger D.

DeLong C.

et al. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J Neurosci. 29 : 6771-6779 View in Article Scopus (135)

PubMed

Crossref

Google Scholar

Sadowski M.J.

Pankiewicz J.

Scholtzova H.

Mehta P.D.

Prelli F.

Quartermain D.

et al. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer’s disease. Proc Natl Acad Sci U S A. 103 : 18787-18792 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Pankiewicz J.E.

Guridi M.

Kim J.

Asuni A.A.

Sanchez S.

Sullivan P.M.

et al. Blocking the apoE/Abeta interaction ameliorates Abeta-related pathology in APOE epsilon2 and epsilon4 targeted replacement Alzheimer model mice. Acta Neuropathol Commun. 2 : 75 View in Article PubMed

Google Scholar

Vitek M.P.

Christensen D.J.

Wilcock D.

Davis J.

Van Nostrand W.E.

Li F.Q.

et al. APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer’s disease transgenics. Neurodegener Dis. 10 : 122-126 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Sweet R.A.

MacDonald M.L.

Kirkwood C.M.

Ding Y.

Schempf T.

Jones-Laughner J.

et al. Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease. Mol Cell Proteomics. 15 : 2252-2262 View in Article Scopus (4)

PubMed

Crossref

Google Scholar

Ji Y.

Gong Y.

Gan W.

Beach T.

Holtzman D.M.

Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer’s disease patients. Neuroscience. 122 : 305-315 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

Dumanis S.B.

Tesoriero J.A.

Babus L.W.

Nguyen M.T.

Trotter J.H.

Ladu M.J.

et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 29 : 15317-15322 View in Article Scopus (105)

PubMed

Crossref

Google Scholar

Klein R.C.

Mace B.E.

Moore S.D.

Sullivan P.M. Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Neuroscience. 171 : 1265-1272 View in Article Scopus (28)

PubMed

Crossref

Google Scholar

Wang C.

Wilson W.A.

Moore S.D.

Mace B.E.

Maeda N.

Schmechel D.E.

et al. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis. 18 : 390-398 View in Article Scopus (64)

PubMed

Crossref

Google Scholar

Kitamura H.W.

Hamanaka H.

Watanabe M.

Wada K.

Yamazaki C.

Fujita S.C.

et al. Age-dependent enhancement of hippocampal long-term potentiation in knock-in mice expressing human apolipoprotein E4 instead of mouse apolipoprotein E. Neurosci Lett. 369 : 173-178 View in Article Scopus (14)

PubMed

Crossref

Google Scholar